Valuation: Aprogen Medicines Inc.

Market Cap 40.27B 30.16M 27.4M 25.32M 22.87M 43.15M 2.83B 44.67M 304M 121M 1.52B 113M 111M 4.81B P/E 2024
-3.44x
P/E 2025 -2.95x
Enterprise Value 177B 133M 121M 112M 101M 190M 12.47B 197M 1.34B 531M 6.69B 498M 488M 21.2B EV / Sales 2024
1.93x
EV / Sales 2025 2.99x
Free-Float
61.67%
Yield 2024 *
-
Yield 2025 -
09-23 Aprogen Biologics Inc. announced that it has received KRW 20.0000011 billion in funding from Aprogen Medicines Inc. CI
09-23 Aprogen Medicines Inc. announced that it has received KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc. CI
09-21 Aprogen Medicines Inc.(KOSE:A007460) dropped from S&P Global BMI Index CI
09-03 Aprogen Medicines Inc. announced that it expects to receive KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc. CI
09-03 Aprogen Biologics Inc. announced that it expects to receive KRW 20.0000011 billion in funding from Aprogen Medicines Inc. CI
08-21 Aprogen Medicines Inc. announced that it has received KRW 2 billion in funding from Jade New Technology Association CI
08-14 Aprogen Medicines Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
08-10 Aprogen Medicines Inc. announced that it expects to receive KRW 2 billion in funding from Jade New Technology Association CI
07-27 Aprogen Biologics Inc. announced that it has received KRW 2.000000772 billion in funding from Aprogen Medicines Inc. CI
07-23 Aprogen Medicines Inc. announced that it has received KRW 2 billion in funding CI
07-14 Aprogen Medicines to Raise 2 Billion Won Through Convertible Bond Issue MT
07-14 Aprogen Biologics Inc. announced that it expects to receive KRW 2.000000772 billion in funding from Aprogen Medicines Inc. CI
07-13 Aprogen Medicines Inc. announced that it expects to receive KRW 2 billion in funding CI
1 day-3.62%
1 week+5.41%
Current month-3.05%
1 month-8.20%
3 months-29.46%
6 months-61.51%
Current year-82.66%
1 week 1,808
Extreme 1808.00000000
2,050
1 month 1,615
Extreme 1615
2,050
Current year 1,615
Extreme 1615
11,880
1 year 1,615
Extreme 1615
14,070
3 years 1,615
Extreme 1615
28,410
5 years 1,615
Extreme 1615
94,950
10 years 1,615
Extreme 1615
875,250
Manager TitleAgeSince
Chief Executive Officer 63 27/12/2017
Corporate Officer/Principal 53 31/03/2026
Comptroller/Controller/Auditor 69 28/03/2018
Director TitleAgeSince
Director/Board Member 70 13/10/2023
Director/Board Member 63 29/11/2022
Director/Board Member 53 31/03/2026
Date Insider Type Main position Quantity % Market Cap. Importance
17/01/25 Others 7,673 0.0025% -
19/01/24 Free 101,429 0.0383%
19/01/24 Free 198,187 0.0748%
Change 5-day change 1-year change 3-year change Capi.($)
-3.62%+5.41%-82.83%-86.57% 30.16M
-2.18%-2.28%+12.36%+119.21% 118B
-0.18%+2.24%+23.81%+21.61% 88.98B
+0.44%+3.32%+61.49%+88.14% 70.02B
-0.14%+0.99%+36.24%+81.70% 63.23B
-4.05%-1.16%+59.52%+115.08% 48.63B
-1.28%-3.74%+55.98%+71.16% 32.77B
-1.92%-3.97%+10.55%+18.85% 32.04B
-2.08%-5.39%+2.93%+29.41% 30.96B
-1.82%-3.22%+12.56%+49.86% 27.42B
Average -1.68%+0.14%+19.26%+50.85% 51B
Weighted average by Cap. -1.30%+1.74%+30.61%+74.46%

Financials

2024 2025
Net sales 150B 112M 102M 94.37M 85.24M 161M 10.56B 167M 1.13B 450M 5.66B 422M 413M 17.94B 118B 88.36M 80.27M 74.17M 66.99M 126M 8.3B 131M 892M 353M 4.45B 332M 325M 14.1B
Net income -58.08B -43.5M -39.52M -36.51M -32.98M -62.24M -4.08B -64.43M -439M -174M -2.19B -163M -160M -6.94B -70.2B -52.58M -47.77M -44.13M -39.86M -75.23M -4.94B -77.88M -531M -210M -2.65B -197M -193M -8.39B
Net Debt 70.04B 52.46M 47.66M 44.03M 39.77M 75.06M 4.93B 77.7M 530M 210M 2.64B 197M 193M 8.37B 137B 103M 93.29M 86.19M 77.85M 147M 9.64B 152M 1.04B 411M 5.17B 385M 377M 16.39B
Projected Income Statement - Annual - Aprogen Medicines Inc.
Logo Aprogen Medicines Inc.
Aprogen Inc, formerly Aprogen Medicines Inc, is a Korea-based company mainly engaged in the business of hardfacing. The Company operates its business through six segments. The Hardfacing segment is engaged in the provision of hardfacing for maintenance of steel mills, thermal power plants and cement plants. The Steel Sale segment is engaged in the sale of steel products, aluminum ingots and others. The Insulation segment is engaged in the nuclear thermal insulation and insulation construction. The Pharmaceutical segment is engaged in the manufacture and sale of pharmaceuticals. The Game segment is engaged in the mobile game publishing business. The Other segment is engaged in the sale of scrap metal.
Employees
160
Date Price Change Volume
16/11/26 ₩1,813.00 -3.62% 62,618
13/11/26 ₩1,881.00 -0.21% 42,198
12/11/26 ₩1,885.00 -3.83% 58,498
11/11/26 ₩1,960.00 +4.37% 118,273
10/11/26 ₩1,878.00 +9.19% 152,920
  1. Stock Market
  2. Stocks
  3. A007460 Stock